Home | News | Directories | Calendar | Maps | Contact Us | Webmail
Perelman School of Medicine at the University of Pennsylvania Advanced Search

Ronac Mamtani, MD, MSCE

Ronac Mamtani, MD, MSCE

faculty photo
Assistant Professor of Medicine at the Hospital of the University of Pennsylvania
Department: Medicine

Contact information
16 Penn Tower
3400 Spruce Street
Philadelphia, PA 19147
Office: 215-265-3040
Education:
BS
Cornell University, 2002.
MD (Internal Medicine)
Stony Brook School of Medicine, 2006.
MS (Clinical Epidemiology)
University of Pennsylvania , 2012.
Permanent link
 
Perelman School of Medicine > Faculty > Search

Selected Publications

Mamtani R, Pfanzelter N, Haynes K, Finkelman BS, Wang X, Keefe SM, Haas NB, Vaughn DJ, Lewis JD.: Incidence of Bladder Cancer in Patients With Type 2 Diabetes Treated With Metformin or Sulfonylureas. Diabetes Care FEB 2014.

Mamtani R, Finkelman BS, Haynes K, Scott FI, Lewis JD: Distinguishing Incident and Prevalent Diabetes in an Electronic Medical Record Database. Pharmacoepidemiology Drug Safety 23(2), FEB 2014.

James D Lewis, Brian L Strom, Laurel Habel, Tiffany Peng, Monique Hedderson, Warren Bilker, Charles Quesenberry, Ronac Mamtani, Lisa Nessel, David Vaughn, Assiamira Ferrara.: Relative Risk of Bladder Cancer with Pioglitazone for Diabetes Mellitus: An Updated 8-Year Interim Report of a 10-Year Follow-Up Study. International Society for Pharmacoepidemiology AUG 2013 Notes: Oral Presentation, Montreal.

Jeurkar, N, Mamtani, R, Vaughn, DJ: Granulomatosis and Testicular Germ Cell Tumors. Urology 80(6): 1303-1306, DEC 2012.

Mamtani, R, Haynes, K, Bilker, WB, Vaughn, DJ, Strom, BL, Glanz, K, Lewis, JD: Association Between Longer Therapy With Thiazolidinediones and Risk of Bladder Cancer: A Cohort Study. Journal Of The National Cancer Institute 104(18): 1411-1421, SEP 2012.

Mamtani, R, Haynes, K, Bilker, WB, Vaughn, DJ, Strom, BL, Glanz, K, Lewis, JD: Long-Term Therapy with Thiazolidinediones May Be Associated with Increased Incidence of Bladder Cancer. Pharmacoepidemiology And Drug Safety 21(3): 25, AUG 2012 Notes: Oral Abstract Presentation, International Society for Pharmacoepidemiology, Barcelona, 2012.

Mamtani R, Haynes K, Bilker WB, Vaughn DJ, Strom BL, Glanz K, Lewis JD: Long-term therapy with thiazolidinediones and the risk of bladder cancer. American Society of Clinical Oncology, 2012 Notes: Oral Abstract Presentation, Chicago, 2012.

Mamtani, R, Vaughn, DJ: Vinflunine in the treatment of advanced bladder cancer. Expert Review Of Anticancer Therapy 11(1): 13-20, JAN 2011.

Brose MS, Troxel AB, Mamtani R: Phase II trial of everolimus with sorafenib for patients with differentiated thyroid cancer (DTC) who progress on sorafenib alone. American Society of Clinical Oncology 2010 Notes: Trials in Progress Poster Session, Chicago, 2010.

Focosi, D, Carson, K, Evens, A, Richey, E, Habermann, T, Seymour, J, Laubach, J, Bawn, S, Gordon, L, Winter, J, Vose, J, Zelenetz, A, Mamtani, R, Raisch, D, Dorshimer, G, Rosen, S, Muro, K, Gottardi-Littell, N, Talley, R, Sartor, O, Green, D, Major, E, Bennett, C, Petrini, M: Progressive Multifocal Leukoencephalopathy Following Rituximab Therapy in HIV Negative Patients: A Report of 56 Cases from the Research on Adverse Drug Event and Reports (RADAR) Project. Haematologica-the Hematology Journal 94: 445, JUN 2009.

back to top
Last updated: 02/17/2014
The Trustees of the University of Pennsylvania